Advertisement

Intra-aortic Balloon Pump

  • Daniel Dante Yeh
Chapter

Abstract

In the twenty-first century, there are several mechanical options for the support of a failing heart. One of the oldest methods is intra-aortic balloon pump (IABP), also known as “counterpulsation.” Despite the proliferation of other options, IABP remains the most common assist device for several reasons: it is minimally invasive, does not require extracorporeal handling of blood, causes minimal hemolysis, and can be inserted in multiple settings (catheterization lab, operating room, intensive care unit, etc.) by both surgeons and interventional cardiologists. This chapter will review the indications for IABP counterpulsation, describe the physiologic mechanisms supporting its use, describe the technique of insertion as well as potential complications, and finally describe the outcomes reported by clinical trials.

Keywords

Aortic balloon pump Cardiac failure Systolic function Electrocardiogram Ejection fraction Cardiac output 

References

  1. 1.
    White JM, Ruygrok PN. Intra-aortic balloon counterpulsation in contemporary practice - where are we? Heart Lung Circ. 2015;24(4):335–41.CrossRefGoogle Scholar
  2. 2.
    Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97(9):1391–8.CrossRefGoogle Scholar
  3. 3.
    Moulopoulos SD. Intra-aortic balloon counterpulsation 50 years later: initial conception and consequent ideas. Artif Organs. 2011;35(9):843–8.CrossRefGoogle Scholar
  4. 4.
    Hanlon-Pena PM, Quaal SJ. Intra-aortic balloon pump timing: review of evidence supporting current practice. Am J Crit Care. 2011;20(4):323–33; quiz 334.CrossRefGoogle Scholar
  5. 5.
    Kapelios CJ, et al. Counterpulsation: a concept with a remarkable past, an established present and a challenging future. Int J Cardiol. 2014;172(2):318–25.CrossRefGoogle Scholar
  6. 6.
    Webb CA, Weyker PD, Flynn BC. Management of intra-aortic balloon pumps. Semin Cardiothorac Vasc Anesth. 2015;19(2):106–21.CrossRefGoogle Scholar
  7. 7.
    Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery. 1953;34(4):678–87.PubMedGoogle Scholar
  8. 8.
    Kantrowitz A, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–8.CrossRefGoogle Scholar
  9. 9.
    Bregman D, et al. Percutaneous intraaortic balloon insertion. Am J Cardiol. 1980;46(2):261–4.CrossRefGoogle Scholar
  10. 10.
    Abnousi F, et al. The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock. Curr Cardiol Rep. 2015;17(6):40.CrossRefGoogle Scholar
  11. 11.
    Ferguson JJ 3rd, et al. The current practice of intra-aortic balloon counterpulsation: results from the benchmark registry. J Am Coll Cardiol. 2001;38(5):1456–62.CrossRefGoogle Scholar
  12. 12.
    Stone GW, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol. 2003;41(11):1940–5.CrossRefGoogle Scholar
  13. 13.
    Achour H, et al. Mechanical left ventricular unloading prior to reperfusion reduces infarct size in a canine infarction model. Catheter Cardiovasc Interv. 2005;64(2):182–92.CrossRefGoogle Scholar
  14. 14.
    Azevedo CF, et al. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J. 2005;26(12):1235–41.CrossRefGoogle Scholar
  15. 15.
    LeDoux JF, et al. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model. Catheter Cardiovasc Interv. 2008;72(4):513–21.CrossRefGoogle Scholar
  16. 16.
    Ohman EM, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation. 1994;90(2):792–9.CrossRefGoogle Scholar
  17. 17.
    Kono T, et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996;28(4):876–81.CrossRefGoogle Scholar
  18. 18.
    Patel MR, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306(12):1329–37.CrossRefGoogle Scholar
  19. 19.
    Vijayalakshmi K, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol. 2007;19(8):339–46.PubMedGoogle Scholar
  20. 20.
    Ihdayhid AR, Chopra S, Rankin J. Intra-aortic balloon pump: indications, efficacy, guidelines and future directions. Curr Opin Cardiol. 2014;29(4):285–92.CrossRefGoogle Scholar
  21. 21.
    Ohman EM, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005;19(1):33–9.CrossRefGoogle Scholar
  22. 22.
    Prondzinsky R, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012;37(4):378–84.CrossRefGoogle Scholar
  23. 23.
    Thiele H, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287–96.CrossRefGoogle Scholar
  24. 24.
    Thiele H, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382(9905):1638–45.CrossRefGoogle Scholar
  25. 25.
    Chen EW, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation. 2003;108(8):951–7.CrossRefGoogle Scholar
  26. 26.
    Abdel-Wahab M, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2010;105(7):967–71.CrossRefGoogle Scholar
  27. 27.
    Cheng JM, et al. Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol. 2013;168(4):3758–63.CrossRefGoogle Scholar
  28. 28.
    O’Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82(1):E1–27.CrossRefGoogle Scholar
  29. 29.
    Task Force on the management of, S.T.s.e.a.m.i.o.t.E.S.o.C, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619.CrossRefGoogle Scholar
  30. 30.
    Task Force on Myocardial Revascularization of the European Society of, C, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501–55.CrossRefGoogle Scholar
  31. 31.
    Nieminen MS, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J. 2005;26(4):384–416.CrossRefGoogle Scholar
  32. 32.
    Nanas JN, et al. Myocardial salvage by the use of reperfusion and intraaortic balloon pump: experimental study. Ann Thorac Surg. 1996;61(2):629–34.CrossRefGoogle Scholar
  33. 33.
    Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006;67(1):68–77.CrossRefGoogle Scholar
  34. 34.
    Perera D, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867–74.CrossRefGoogle Scholar
  35. 35.
    Perera D, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127(2):207–12.CrossRefGoogle Scholar
  36. 36.
    Stone GW, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second primary angioplasty in myocardial infarction (PAMI-II) trial investigators. J Am Coll Cardiol. 1997;29(7):1459–67.CrossRefGoogle Scholar
  37. 37.
    van ‘t Hof AW, et al. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999;20(9):659–65.CrossRefGoogle Scholar
  38. 38.
    Bahekar A, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012;17(1):44–56.CrossRefGoogle Scholar
  39. 39.
    Cassese S, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials. Am Heart J. 2012;164(1):58–65 e1.CrossRefGoogle Scholar
  40. 40.
    Sjauw KD, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30(4):459–68.CrossRefGoogle Scholar
  41. 41.
    Levine GN, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44–122.CrossRefGoogle Scholar
  42. 42.
    Buckley MJ, et al. Intra-aortic balloon pump assist for cardiogenic shock after cardiopulmonary bypass. Circulation. 1973;48(1 Suppl):III90–4.PubMedGoogle Scholar
  43. 43.
    Christenson JT, et al. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg. 1997;64(5):1237–44.CrossRefGoogle Scholar
  44. 44.
    Christenson JT, Licker M, Kalangos A. The role of intra-aortic counterpulsation in high-risk OPCAB surgery: a prospective randomized study. J Card Surg. 2003;18(4):286–94.CrossRefGoogle Scholar
  45. 45.
    Christenson JT, et al. Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg. 1997;11(6):1097–103; discussion 1104.CrossRefGoogle Scholar
  46. 46.
    Christenson JT, et al. The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF < 40%), and hypertensive LV hypertrophy. Thorac Cardiovasc Surg. 1997;45(2):60–4.CrossRefGoogle Scholar
  47. 47.
    Christenson JT, et al. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg. 1999;68(3):934–9.CrossRefGoogle Scholar
  48. 48.
    Theologou T, et al. Preoperative intra aortic balloon pumps in patients undergoing coronary artery bypass grafting. Cochrane Database Syst Rev. 2011;(1):CD004472. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004472.pub3/full
  49. 49.
    Dyub AM, et al. Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis. J Card Surg. 2008;23(1):79–86.CrossRefGoogle Scholar
  50. 50.
    Kang N, Edwards M, Larbalestier R. Preoperative intraaortic balloon pumps in high-risk patients undergoing open heart surgery. Ann Thorac Surg. 2001;72(1):54–7.CrossRefGoogle Scholar
  51. 51.
    Zangrillo A, et al. Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Crit Care. 2015;19:10.CrossRefGoogle Scholar
  52. 52.
    Torchiana DF, et al. Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg. 1997;113(4):758–64; discussion 764–9.CrossRefGoogle Scholar
  53. 53.
    Christenson JT, et al. Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery. Ann Thorac Surg. 2002;74(4):1086–90; discussion 1090–1.CrossRefGoogle Scholar
  54. 54.
    Arafa OE, et al. Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg. 1998;65(3):741–7.CrossRefGoogle Scholar
  55. 55.
    Marra C, et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomized study on the timing of perioperative intraaortic balloon pump support. Int J Artif Organs. 2002;25(2):141–6.CrossRefGoogle Scholar
  56. 56.
    Cochran RP, et al. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg. 2002;74(3):746–51; discussion 751–2.CrossRefGoogle Scholar
  57. 57.
    Russo MJ, et al. Intra-aortic balloon pump inserted through the subclavian artery: a minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012;144(4):951–5.CrossRefGoogle Scholar
  58. 58.
    Estep JD, et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013;1(5):382–8.CrossRefGoogle Scholar
  59. 59.
    Manord JD, et al. Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. J Vasc Surg. 1997;26(3):511–5; discussion 515–6.CrossRefGoogle Scholar
  60. 60.
    Gjesdal O, et al. Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival. Eur J Heart Fail. 2009;11(7):709–14.CrossRefGoogle Scholar
  61. 61.
    Arafa OE, et al. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg. 2000;70(5):1587–93.CrossRefGoogle Scholar
  62. 62.
    McNamara MW, Dixon SR, Goldstein JA. Impact of intra-aortic balloon pumping on hypotension and outcomes in acute right ventricular infarction. Coron Artery Dis. 2014;25(7):602–7.CrossRefGoogle Scholar
  63. 63.
    Culliford AT, et al. Intra-aortic balloon counterpulsation. Refractory ventricular tachycardia. JAMA. 1978;239(5):431–2.CrossRefGoogle Scholar
  64. 64.
    Willerson JT, et al. Intraaortic balloon counterpulsation in patients in cardiogenic shock, medically refractory left ventricular failure and/or recurrent ventricular tachycardia. Am J Med. 1975;58(2):183–91.CrossRefGoogle Scholar
  65. 65.
    Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Contin Educ Anaesth Crit Care Pain. 2009;9(1):24–8.CrossRefGoogle Scholar
  66. 66.
    de Waha S, et al. Intra-aortic balloon counterpulsation – basic principles and clinical evidence. Vasc Pharmacol. 2014;60(2):52–6.CrossRefGoogle Scholar
  67. 67.
    Kern MJ, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 1993;21(2):359–68.CrossRefGoogle Scholar
  68. 68.
    Capoccia M, et al. Evidence of clinical efficacy of counterpulsation therapy methods. Heart Fail Rev. 2015;20(3):323–35.CrossRefGoogle Scholar
  69. 69.
    Mueller H, et al. The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. J Clin Invest. 1971;50(9):1885–900.CrossRefGoogle Scholar
  70. 70.
    Williams DO, et al. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation. 1982;66(3):593–7.CrossRefGoogle Scholar
  71. 71.
    van Nunen LX, et al. Usefulness of intra-aortic balloon pump counterpulsation. Am J Cardiol. 2016;117(3):469–76.CrossRefGoogle Scholar
  72. 72.
    Scheidt S, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med. 1973;288(19):979–84.CrossRefGoogle Scholar
  73. 73.
    Smalling RW, et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation. 1992;85(3):1152–9.CrossRefGoogle Scholar
  74. 74.
    Schreuder JJ, et al. Automatic intraaortic balloon pump timing using an intrabeat dicrotic notch prediction algorithm. Ann Thorac Surg. 2005;79(3):1017–22; discussion 1022.CrossRefGoogle Scholar
  75. 75.
    Pucher PH, et al. Is heparin needed for patients with an intra-aortic balloon pump? Interact Cardiovasc Thorac Surg. 2012;15(1):136–9.CrossRefGoogle Scholar
  76. 76.
    Jiang CY, et al. Anticoagulation therapy in intra-aortic balloon counterpulsation: does IABP really need anti-coagulation? J Zhejiang Univ Sci. 2003;4(5):607–11.CrossRefGoogle Scholar
  77. 77.
    Boehmer JP, Popjes E. Cardiac failure: mechanical support strategies. Crit Care Med. 2006;34(9 Suppl):S268–77.CrossRefGoogle Scholar
  78. 78.
    Schreuder JJ, et al. Beat-to-beat effects of intraaortic balloon pump timing on left ventricular performance in patients with low ejection fraction. Ann Thorac Surg. 2005;79(3):872–80.CrossRefGoogle Scholar
  79. 79.
    Urban PM, et al. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. Am J Cardiol. 2004;94(2):181–5.CrossRefGoogle Scholar
  80. 80.
    Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg. 2011;6:147.CrossRefGoogle Scholar
  81. 81.
    Funk M, Gleason J, Foell D. Lower limb ischemia related to use of the intraaortic balloon pump. Heart Lung. 1989;18(6):542–52.PubMedGoogle Scholar
  82. 82.
    Cohen M, et al. Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J. 2000;139(2 Pt 1):282–7.PubMedGoogle Scholar
  83. 83.
    Anderson RD, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 1997;30(3):708–15.CrossRefGoogle Scholar
  84. 84.
    Iqbal MB, et al. Intra-aortic balloon pump counterpulsation during primary percutaneous coronary intervention for ST-elevation myocardial infarction and cardiogenic shock: insights from the British Columbia Cardiac Registry. PLoS One. 2016;11(2):e0148931.CrossRefGoogle Scholar
  85. 85.
    Barron HV, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of myocardial infarction 2. Am Heart J. 2001;141(6):933–9.CrossRefGoogle Scholar
  86. 86.
    Jones HA, et al. Left ventricular assist for high-risk percutaneous coronary intervention. J Invasive Cardiol. 2012;24(10):544–50.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryRyder Trauma CenterMiamiUSA

Personalised recommendations